WF5-46144-64903

3 vaccinations 10 coded responses 23 check-ins 10 free-text entries 4 call cases

Sex: —
Age at first dose: 46-50
ZIP prefix: 152 / PA
Registered: 2021-01-10

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Registered dependents

4FR-26263-55587 Child or adolescent in my care · Female · 2022-07-01

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-10
Registered in v-safe
2021-01-10
Dose 1 — Pfizer-BioNTech
2021-01-13
Survey response — days 1–6 daily, dose 1
MedDRA: Oropharyngeal pain — Feeling: Good · Site: Pain · Headache, Fatigue or tiredness

Free text: Sore throat

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-14
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-01-15
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-01-17
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-24
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-29
Dose 2 — Pfizer-BioNTech
2021-01-30
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-01-30
Survey response — day 0, dose 2
MedDRA: Dizziness — Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-31
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, Nausea

Adult check-in
2021-02-01
Survey response — days 1–6 daily, dose 2
MedDRA: Decreased appetite, Insomnia — Feeling: Good · Site: Pain · Fatigue or tiredness

Free text: Lack of appetite and difficulty sleeping

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-02
Survey response — days 1–6 daily, dose 2
MedDRA: Tachycardia — Feeling: Good · Site: Pain · Headache, Fatigue or tiredness

Free text: Tachycardia

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-03
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-02-04
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-06
Health check-in — day 7, dose 2
Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-02-12
Survey response — day 14, dose 2
MedDRA: Headache, Ophthalmic migraine — Feeling: Fair · Be unable to do your normal daily activities

Free text: 72 hr of ocular migraine, then min-mod HA for 3 days.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-19
Survey response — day 21, dose 2
MedDRA: Cough, Headache, Malaise, Oropharyngeal pain, Pain, Pyrexia, SARS-CoV-2 test — Feeling: Fair · Be unable to work, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Fever, cough, headache, body aches, sore throat, malaise. Pending COVID test.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-19
Report sent to call center — day 21, dose 2
Be unable to work · Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-26
Survey response — day 28, dose 2
MedDRA: Migraine — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Unremitting migraine - 5 days.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-26
Report sent to call center — day 28, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-03-05
Survey response — day 35, dose 2
MedDRA: Hypertension, Migraine — Feeling: Fair · Be unable to do your normal daily activities

Free text: Hypertension and migraine - 2x this week, I do not have a history of HTN.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-14
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-30
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-08-01
Survey response — 6 months, dose 2
MedDRA: Arthralgia — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Joint pain

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-08-01
Report sent to call center — 6 months, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-08-04
Call 1 — Left Voicemail
2021-10-06
Dose 3 — Pfizer-BioNTech
Co-administered: Flu
2022-01-29
Health check-in — 12 months, dose 2
Feeling: Fair

Adult check-in
2022-04-06
Survey response — 6 months, dose 3
MedDRA: Gestational hypertension, Supraventricular tachycardia — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Gestational Hypertension, SVTs

MedDRA releases: 2024-11 · check-in free text available
2022-04-06
Report sent to call center — 6 months, dose 3
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-04-11
Call successful
Participant prefers to complete VAERS report online
2022-10-07
Health check-in — 12 months, dose 3
Feeling: Fair

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-10	Pfizer-BioNTech
2	2021-01-29	Pfizer-BioNTech
3	2021-10-06	Pfizer-BioNTech	Flu

Call center

Reported	Outcome	VAERS-related outcome
2021-02-19	Successful	Participant prefers to complete VAERS report online
2021-02-26	Successful	Participant prefers to complete VAERS report online
2021-08-01	Successful	Participant prefers to complete VAERS report online
2022-04-06	Successful 2022-04-11	Participant prefers to complete VAERS report online

Free text

Release 1 — days 1–6 daily, dose 1

2021-01-13

Systemic reaction (other): Sore throat

Release 3 — day 0, dose 2

2021-01-30

Systemic reaction (other): Dizziness

Release 3 — days 1–6 daily, dose 2

2021-02-01

Systemic reaction (other): Lack of appetite and difficulty sleeping

2021-02-02

Systemic reaction (other): Tachycardia

Release 4 — day 14, dose 2

2021-02-12

Symptoms: 72 hr of ocular migraine, then min-mod HA for 3 days.

Release 4 — day 21, dose 2

2021-02-19

Symptoms: Fever, cough, headache, body aches, sore throat, malaise. Pending COVID test.

Release 4 — day 28, dose 2

2021-02-26

Symptoms: Unremitting migraine - 5 days.

Release 5 — day 35, dose 2

2021-03-05

Symptoms: Hypertension and migraine - 2x this week, I do not have a history of HTN.

Release 9 — 6 months, dose 2

2021-08-01

Symptoms: Joint pain

Release 11 — 6 months, dose 3

2022-04-06

Symptoms: Gestational Hypertension, SVTs

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Arthralgia	✓	·	✓
SD	Cough	✓	✓	✓
SD	Gestational hypertension	·	·	✓
SD	Headache	✓	✓	✓
SD	Hypertension	✓	✓	✓
SD	Malaise	✓	✓	✓
SD	Migraine	✓	✓	✓
SD	Ophthalmic migraine	✓	✓	✓
SD	Oropharyngeal pain	✓	✓	✓
SD	Pain	✓	✓	✓
SD	Pyrexia	✓	✓	✓
SD	SARS-CoV-2 test	✓	✓	✓
SD	Supraventricular tachycardia	·	·	✓
SRO	Decreased appetite	✓	✓	✓
SRO	Dizziness	✓	✓	✓
SRO	Insomnia	✓	✓	✓
SRO	Oropharyngeal pain	✓	✓	✓
SRO	Tachycardia	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release